Market closed

Hoth Therapeutics Inc./$HOTH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Ticker

$HOTH
Trading on

Industry

Pharmaceuticals

Employees

3

HOTH Metrics

BasicAdvanced
$13M
-
-$1.28
0.64
-
$13M
0.64
$1.29
$0.66
460K
9.197
8.525
0.039
0.452
-57.19%
-99.75%
1.13
1.13
-0.885
-45.98%
-56.88%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HOTH

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Hoth Therapeutics Inc. stock?

What is the P/E ratio for Hoth Therapeutics Inc. stock?

Does Hoth Therapeutics Inc. stock pay dividends?

When is the next Hoth Therapeutics Inc. dividend payment date?

What is the beta indicator for Hoth Therapeutics Inc.?